Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: hepatitis + lymphoma + 0.13  Related to the article below (Last Update: 8/5/2008)

"Pharmed" vaccine passes early test
Scientist, UK - Jul 21, 2008
A team of researchers has completed human tests of the first plant-produced vaccine for non-Hodgkin's lymphoma. The successful results of a phase I clinical ...

GNIF Brain Blogger
Viruses Cause Cancer?
GNIF Brain Blogger, CA - Jul 30, 2008
Some examples he gave were liver cancer, caused by chronic Hepatitis B and C, and MALT lymphoma and adenocarcinoma of the stomach caused by Helicobacter ...
The climb of their lives: Cousins celebrate 50th birthdays with ...
Eagle Tribune, MA - Aug 2, 2008
On Christmas Eve 1993, Burke-Fogg was diagnosed with Hodgkin's lymphoma. Her 10-month battle involved extreme fatigue and a difficult time even getting ...
Medarex Highlights Strength in Antibody Development and Underlying ...
FOXBusiness - Jul 10, 2008
MDX-1401 is a fully human antibody that targets CD30, a member of the TNF family expressed on CD30-positive lymphomas, including Hodgkin's lymphoma. ...MEDX - OTC:CMTX
Roche posts very good results: strong market outperformance ...
Business-News, Switzerland - Jul 20, 2008
MabThera/Rituxan is also benefiting from increasing use as maintenance therapy for relapsed follicular lymphoma in Europe and the United States. ...
New guidelines for treating rheumatoid arthritis
HULIQ (press release), NC - Jul 24, 2008
... hepatitis C and active or latent tuberculosis. Doctors should not prescribe anti-TNF agents to patients with a history of heart failure, lymphoma or ...
BUYINS.NET: FLML, GEOI, JADE, LAMR, NOEC, ZGEN Have Also Been ...
Trading Markets (press release), CA - Jul 14, 2008
... non-Hodgkin's lymphoma, colorectal cancer, and ovarian cancer; PEG-IFN-l for the treatment of hepatitis C virus infection and multiple sclerosis; ...FLML - JADE - GEOI
MRC Technology and Biolex Therapeutics Successfully Complete ...
Market Wire (press release) - Jul 14, 2008
... that MRCT had successfully completed the humanization of a novel antibody targeting CD20, indicated in non-Hodgkin's lymphoma and rheumatoid arthritis. ...
Biologics and Combinations Top Arthritis Recommendations
MedPage Today, NJ - Jul 24, 2008
Prohibition on anti-TNF agents in patients who have a history of heart failure, lymphoma, or multiple sclerosis. Dr. Saag and many of the co-authors ...
Roche profit slip overshadowed by bid to buy all of Genentech
Pharma Times (subscription), UK - Jul 21, 2008
MabThera/Rituxan for non-Hodgkin?s lymphoma grew 17% to 2.87 billion francs, while sales of Herceptin were up 11% to 2.47 billion francs. ...DNA
Source: Google News

… lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection -
AS Duberg, M Nordstrom, A Torner, O Reichard, R … - Hepatology, 2005 - doi.wiley.com
... MM 0?14 years 0 0.13 ? ? ... than the median or mean age among NHL patients with hepatitis
C in ... role of HCV infec- tion in the genesis of lymphoma is found ...

Extrahepatic manifestations of hepatitis C among United States male veterans -
H El-Serag? - Hepatology, 2002 - doi.wiley.com
... Abbreviations: HCV, hepatitis C virus; MPGN, membranoproliferative glomer ... planus
104 (0.30) 178 (0.13) 2.34 (1.84-2.98 ... Lymphoma Non-Hodgkin?s lymphoma 421 (1.23 ...

Viral Elimination Reduces Incidence of Malignant Lymphoma in Patients with Hepatitis C -
Y Kawamura, K Ikeda, Y Arase, H Yatsuji, H Sezaki, … - The American Journal of Medicine, 2007 - Elsevier
... lymphoma among patients with hepatitis C virus ... with persistent infection (hazard
ratio: 0.13; P = .049 ... the annual incidence of malignant lymphoma among patients ...

Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma
F Wang, R Xu, H Luo, D Zhang, W Jiang, H Huang, X … - BMC Cancer, 2008 - pubmedcentral.nih.gov
... between the two sub-groups was not significant (p-value 0.13). ... J, Morinaga S, Mutou
Y. Safety of rituximab in lymphoma patients with hepatitis B or ...

LIVER DYSFUNCTION AFTER CHEMOTHERAPY IN LYMPHOMA PATIENTS INFECTED WITH HEPATITIS C -
O Dizdar, U Tapan, S Aksoy, H Harputluoglu, S … - European Journal of Haematology, 2008 - Blackwell Synergy
... 15%, p=0.13). No patients received rituximab in this study [16]. ... Characteristics
and outcome of diffuse large B-cell lymphoma in hepatitis C virus- ...
-

[PDF] THE RELATION OF LYMPHOMAAND HEPATITIS B VIRUS/HEPATITIS C VIRUS INFECTIONS IN THE REGION OF EAST … -
M Sonmez, O Bektas, M Yilmaz, A Durmus, E Akdogan, … - Tumori, 2007 - tumorionline.it
... Hepatitis B surface antigen (HBsAg) and anti-HCV ... HCV Ab positivity was 2.8% in lymphoma
patients, compared ... P = 0.4, OR = 0.53, 95% CI, 0.13-1.86, respectively ...

Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C
F Password - European Journal of Haematology, 2008 - Blackwell Synergy
... 15%, P = 0.13). ... with lymphoplasmacytoid lymphoma and follicular lymphoma received
either ... increased HCV-related hepatotoxicity/hepatitis following chemotherapy ...

Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps … -
M Zignol, M Peracchi, G Tridello, M Pillon, F … - Cancer, 2004 - doi.wiley.com
... 6.29 0.001 14/67 vs. 0/9 0.13 76 Tetanus 5/61 vs. ... 0/11 0.30 77 M: male: F: female;
HBV: hepatitis B virus. a Leukemia/lymphoma versus solid tumor. ...

… of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection -
P Cacoub, M Bourliere, P Hausfater, F Charlotte, H … - Journal of Viral Hepatitis, 2003 - Blackwell Synergy
... factor of B-cell non-Hodgkin lymphoma (B-NHL ... with an histologically proven chronic
active hepatitis of whom ... of CD81 receptor (OR = 0.34, 95% CI = 0.13?0.89, P ...

… B cell populations in the blood and liver of patients with chronic hepatitis C virus infection -
L Vallat, Y Benhamou, M Gutierrez, P Ghillani, C … - Arthritis and Rheumatism, 2004 - doi.wiley.com
... Blood /liver III 0 ND * HCV hepatitis C virus; NHL non-Hodgkin?s lymphoma; MK IgM ;
GL IgG ; WM Waldenstr?m?s macroglobulinemia; ND not determined. ...

Source: Google Scholar
 

Hepatitis C linked with non-Hodgkin's lymphoma

Last Updated: 2007-05-08 16:21:20 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Individuals who are infected with the hepatitis C virus have an increased risk of developing non-Hodgkin's lymphoma and other diseases of the lymph system, investigators report in the Journal of the American Medical Association.

Dr. Thomas P Giordano and colleagues at the Michael E. DeBakey Veterans Affairs Medical Center in Houston and investigators at the National Cancer Institute in Rockville, Maryland, used data compiled from Veterans Affairs administrative records. These records are of particular interest because the rates of hepatitis C virus infection are nearly three times higher in veterans than in the general population.

Giordano and colleagues searched for associations among hepatitis C virus, leukemias and other types of lymphomas in 146,000 hepatitis C virus-infected patients and 572,000 uninfected control subjects. The average follow-up was 2.3 years.

Article continues below and (thank you)
 

The subjects with hepatitis C virus infection had a 28-percent increased risk of non-Hodgkin's lymphoma and nearly three times the risk of Waldenstrom macroglobulinemia, a rare, slow-growing cancer of the lymph system.

Hepatitis C patients also had a nearly four-fold risk of cryoglobulinemia, a condition marked by the presence of abnormal proteins in the bloodstream which thicken or gel on exposure to cold. They also had a small risk of thyroiditis, inflammation of the thyroid gland.

Hepatitis C virus infection precedes development of these conditions, Giordano and colleagues conclude. They also suggest "the intriguing possibility" that chronic immune stimulation by hepatitis C virus can result in a progression along a broad spectrum of diseases, ranging from apparently benign to malignant conditions.

SOURCE: Journal of the American Medical Association May 9, 2007.

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
 
Google
Web www.iconocast.com
 
 
Continue News With: News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; Nedws9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast